This report presents a strategic analysis of the Egypt Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Vaccines Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Women's Health Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Women's Health Market, offering unmatched value, accuracy and expert insights.
The Egypt Hospital Market was valued at $15.40 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $28.33 Bn by 2030. The key drivers of this industry are the increasing prevalence of chronic disease, technological advancements, and investment in healthcare infrastructure. The key players in the industry are Cleopatra Hospitals Group, Al Safwa Hospital Group, Zohairy Hospital, and Andalusia Hospital among others.
The Egypt Chronic Pain Therapeutics Market is anticipated to experience a growth from $208 Mn in 2022 to $368 Mn by 2030, with a CAGR of 7.4% during the forecast period of 2022-2030. The key drivers include the rising prevalence of age-related chronic conditions, a growing healthcare expenditure, and a rising awareness leading to a demand for alternative and safer pain management options. The Egypt Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Sanofi, Roche, Merck, Abbott, AstraZeneca, EVA Pharma, Pharco, EIPICO, etc., among various others.
The Egypt Cold Pain Therapy Market was valued at $6 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $10 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, expanded product offerings, and supportive government initiatives. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
The Egypt Dental Fluoride Treatment Market was valued at $42.5 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $61.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Sigma Pharmaceuticals Industries, Arab Drug Company, MACRO Group, Pharco Pharmaceuticals and Hindustan Unilever Limited among others.
The Egypt Financial Assistance Programs Market was valued at $79.3 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $225.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Roche, Pfizer, Bayer, Merck, GSK, Johnson & Johnson, Novartis among others.
The Egypt Periodontal Therapeutics Market was valued at $2.4 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $4.4 Mn by 2030. Egypt Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Egypt Chronic Cough Therapeutics Market was valued at $18 Mn in 2022 and is estimated to reach $37 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Merck & Co., AstraZeneca, Abbott Laboratories, Bayer AG, and Chiesi Farmaceutici.
The Egypt Radiology Service Market was valued at $11.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $32 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Egypt Radiology Service Market are Andalusia Al Maadi Hospital, Dar Al Fouad Hospital, As-Salam International Hospital, Andalusia Al Shalalat Hospital, and Arab Contractors Medical Center (ACMC), among others.
The Egypt MRI Market was valued at $18.59 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $31.86 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic diseases, improved quality of healthcare services, and emphasis on research and development. The key players in the industry are GE Healthcare, Esaote, Philips Healthcare Egypt, and Fujifilm Healthcare among others.
The Egypt Conjunctivitis Therapeutics Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $20 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare infrastructure, and the evolving treatment landscape. The industry is primarily dominated by players such as Allergan, Sun Pharma, Novartis, Sirion, Boehringer Ingelheim, Pfizer, and Auven among others.
The Egypt Hypersomnia Therapeutics Market was valued at $14.95 Mn in 2023 and is predicted to grow at a CAGR of 5.73% from 2023 to 2030, to $22.08 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Delta Pharma, Teva, Sedico Pharmaceuticals, and Takeda Pharmaceuticals among others.
Egypt Dental Implant Market was valued at $14 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $29.60 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental awareness, and advanced dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Egypt Head and Neck Cancer Therapeutics Market was valued at $7.93 Mn in 2023 and is predicted to grow at a CAGR of 13.73% from 2023 to 2030, to $19.52 Mn by 2030. The key drivers of this industry include government initiatives, the aging population, and advancements in treatment options. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
The Egypt PET Scan Market was valued at $5.4 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $8.7 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Egypt PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Egypt Compression Therapy Market was valued at $11 Mn in 2022 and is estimated to reach $18 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The increasing incidence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Mölnlycke Health Care, Sigvaris Group, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, Medi-Globe Pharmaceuticals, Aspen Pharmacare, FBNQuest Healthcare, and Juzo.
Egypt Genomic Diagnostics Market was valued at $91.42 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $291.22 Mn by 2030. The key drivers of this industry include Growing Healthcare Expenditure, Advancements in Technology, and Government Initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
The Egypt Exosome Research Market was valued at $0.5 Mn in 2023 and is projected to grow at a CAGR of 17.5% from 2023 to 2023, to $1.5 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, Bio-Techne Crop, QIAGEN, Beckam Coulter, Lonza among others.
The Egypt Mouth Ulcer Therapeutics Market was valued at $4.3 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $6.2 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as EIPICO, Pharco Pharmaceuticals, Amoun Pharmaceuticals, GlaxoSmithKline PLC, among others.